Free Trial

HIVE Blockchain Technologies (HVBTF) Financials

HIVE Blockchain Technologies logo
$2.60 +0.17 (+7.00%)
As of 05/4/2026
Annual Income Statements for HIVE Blockchain Technologies

Annual Income Statements for HIVE Blockchain Technologies

This table shows HIVE Blockchain Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-1.88 26 93 -237 27 -3.00
Consolidated Net Income / (Loss)
-1.88 34 80 -236 27 -3.00
Net Income / (Loss) Continuing Operations
-1.66 26 87 -236 27 -3.00
Total Pre-Tax Income
-0.83 24 82 -236 33 1.61
Total Operating Income
-3.13 50 79 -206 -50 -53
Total Gross Profit
2.21 40 97 -31 -26 -39
Total Revenue
30 68 211 106 114 115
Operating Revenue
30 68 211 106 114 115
Total Cost of Revenue
23 1.80 47 120 141 155
Operating Cost of Revenue
23 1.80 47 120 141 155
Total Operating Expenses
11 16 85 193 24 13
Selling, General & Admin Expense
4.74 5.14 18 13 13 17
Other Operating Expenses / (Income)
- 0.00 - - 4.72 4.14
Other Special Charges / (Income)
- - - - 6.17 -7.61
Total Other Income / (Expense), net
2.29 -24 10 -30 83 54
Interest Expense
0.42 1.21 3.87 3.96 3.02 2.29
Interest & Investment Income
0.00 0.80 - -13 0.00 -0.31
Other Income / (Expense), net
2.71 -23 14 -13 86 57
Income Tax Expense
0.83 0.15 2.42 0.29 6.19 4.61
Basic Earnings per Share
($0.01) $0.35 $1.02 ($2.85) $0.29 ($0.02)
Weighted Average Basic Shares Outstanding
326.90M - 77.72M 82.87M 90.01M 127.94M
Diluted Earnings per Share
($0.01) $0.33 $0.94 ($2.85) $0.29 ($0.02)
Weighted Average Diluted Shares Outstanding
326.90M - 84.81M 82.87M 90.01M 127.94M
Weighted Average Basic & Diluted Shares Outstanding
- - - - 90.01M 165.62M

Quarterly Income Statements for HIVE Blockchain Technologies

No quarterly income statements for HIVE Blockchain Technologies are available.


Annual Cash Flow Statements for HIVE Blockchain Technologies

This table details how cash moves in and out of HIVE Blockchain Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Change in Cash & Equivalents
-1.68 35 -70 -2.03 5.31 14
Net Cash From Operating Activities
-1.45 24 -101 -2.86 9.64 17
Net Cash From Continuing Operating Activities
-1.45 23 -101 -2.86 9.64 17
Net Income / (Loss) Continuing Operations
-1.66 24 80 -236 27 -3.00
Consolidated Net Income / (Loss)
-1.66 24 80 -236 27 -3.00
Depreciation Expense
6.30 11 67 82 64 64
Non-Cash Adjustments To Reconcile Net Income
-1.92 -7.74 -209 161 -79 -49
Changes in Operating Assets and Liabilities, net
-0.28 -4.04 -39 -8.96 -1.19 4.37
Net Cash From Investing Activities
0.00 -67 0.00 0.00 -77 -184
Net Cash From Continuing Investing Activities
0.00 -67 0.00 0.00 -77 -184
Purchase of Property, Plant & Equipment
0.00 -21 - - -63 -121
Acquisitions
- -0.97 - 0.00 -0.65 -26
Purchase of Investments
- -0.19 - - -0.34 -1.53
Sale of Property, Plant & Equipment
- 0.00 - - 1.88 19
Sale and/or Maturity of Investments
- -44 - - 0.00 1.78
Other Investing Activities, net
- - - - -15 -57
Net Cash From Financing Activities
0.00 78 32 1.04 73 181
Net Cash From Continuing Financing Activities
0.00 78 32 1.04 73 181
Repayment of Debt
- -3.05 -2.40 -2.77 -4.53 -6.13
Issuance of Common Equity
- 65 34 3.80 77 187
Other Financing Activities, net
- 1.80 - - 0.10 0.10
Effect of Exchange Rate Changes
-0.23 - -0.04 -0.20 0.00 0.10

Quarterly Cash Flow Statements for HIVE Blockchain Technologies

No quarterly cash flow statements for HIVE Blockchain Technologies are available.


Annual Balance Sheets for HIVE Blockchain Technologies

This table presents HIVE Blockchain Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Total Assets
29 178 452 196 307 532
Total Current Assets
5.13 108 5.32 4.37 185 245
Cash & Equivalents
5.13 40 5.32 4.37 9.68 23
Short-Term Investments
- 58 - - 6.97 24
Accounts Receivable
- 8.77 - - 6.93 15
Other Current Assets
- - - - 162 182
Plant, Property, & Equipment, net
177 22 170 66 95 203
Total Noncurrent Assets
21 49 277 126 26 83
Noncurrent Note & Lease Receivables
9.75 - 9.79 15 2.60 3.02
Other Noncurrent Operating Assets
11 49 250 108 24 80
Total Liabilities & Shareholders' Equity
202 178 452 196 307 532
Total Liabilities
8.02 50 63 47 47 82
Total Current Liabilities
2.96 9.86 13 14 27 66
Short-Term Debt
- 4.40 - 2.40 10 8.22
Accounts Payable
2.13 3.48 12 9.35 11 15
Current Deferred & Payable Income Tax Liabilities
- 0.00 1.01 1.85 4.15 7.95
Other Current Liabilities
- 1.91 - - 2.30 34
Total Noncurrent Liabilities
5.06 18 50 34 20 17
Long-Term Debt
2.71 17 31 23 12 10
Noncurrent Deferred & Payable Income Tax Liabilities
- - 1.53 0.21 2.42 3.21
Other Noncurrent Operating Liabilities
0.78 1.15 15 8.62 5.45 3.10
Total Equity & Noncontrolling Interests
194 128 389 149 259 449
Total Preferred & Common Equity
194 123 389 149 259 449
Total Common Equity
194 123 389 149 259 449
Common Stock
189 260 414 419 524 717
Retained Earnings
- -147 -60 -297 -271 -274
Accumulated Other Comprehensive Income / (Loss)
5.71 10 23 7.40 6.33 6.29

Quarterly Balance Sheets for HIVE Blockchain Technologies

No quarterly balance sheets for HIVE Blockchain Technologies are available.


Annual Metrics And Ratios for HIVE Blockchain Technologies

This table displays calculated financial ratios and metrics derived from HIVE Blockchain Technologies' official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
DEI Shares Outstanding
0.00 0.00 0.00 0.00 - 165,615,186.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00 0.00 - 165,615,186.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00 0.00 - -0.02
Growth Metrics
- - - - - -
Revenue Growth
0.00% 121.99% 211.97% -49.66% 10.88% 0.71%
EBITDA Growth
0.00% 528.97% 332.45% -185.55% 119.44% -30.82%
EBIT Growth
0.00% 6,480.36% 253.25% -334.88% 82.02% -88.20%
NOPAT Growth
0.00% 2,361.79% 55.30% -287.73% 82.65% 339.99%
Net Income Growth
0.00% 1,935.12% 131.02% -396.93% 78.34% -111.31%
EPS Growth
0.00% 1,935.12% 131.02% -403.19% 0.00% -106.90%
Operating Cash Flow Growth
0.00% 1,732.70% -528.04% 97.18% -1,418.91% 72.55%
Free Cash Flow Firm Growth
0.00% 0.00% -247.15% 134.60% -243.63% 58.15%
Invested Capital Growth
0.00% -62.24% 447.77% -57.74% 58.67% 58.44%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - -
Gross Margin
7.25% 59.36% 45.89% -29.04% -22.04% -34.13%
EBITDA Margin
19.31% 54.71% 75.83% -128.87% 22.59% 59.60%
Operating Margin
-10.25% 73.58% 37.51% -193.91% -30.34% -45.56%
EBIT Margin
-1.36% 38.94% 44.10% -205.74% -33.35% 3.65%
Profit (Net Income) Margin
-6.16% 50.91% 37.70% -222.37% -43.44% -2.60%
Tax Burden Percent
225.71% 141.86% 97.06% 100.12% 130.23% -185.86%
Interest Burden Percent
201.38% 92.16% 88.09% 107.95% 100.00% 38.26%
Effective Tax Rate
0.00% 0.62% 2.95% 0.00% 0.00% 285.86%
Return on Invested Capital (ROIC)
-1.13% 37.20% 32.54% -50.78% -11.46% 28.50%
ROIC Less NNEP Spread (ROIC-NNEP)
-29.80% 90.61% 20.23% -653.83% -196.68% 888.93%
Return on Net Nonoperating Assets (RNNOA)
0.17% -15.82% -1.75% -37.13% -13.61% -29.34%
Return on Equity (ROE)
-0.97% 21.38% 30.79% -87.91% -25.07% -0.85%
Cash Return on Invested Capital (CROIC)
0.00% 127.56% -105.71% 30.40% -56.83% -16.73%
Operating Return on Assets (OROA)
-1.42% 25.42% 29.54% -67.47% -15.61% 1.01%
Return on Assets (ROA)
-6.45% 33.23% 25.25% -72.93% -20.33% -0.71%
Return on Common Equity (ROCE)
-0.97% 21.04% 30.49% -87.91% -25.07% -0.85%
Return on Equity Simple (ROE_SIMPLE)
-0.97% 28.01% 20.47% -158.87% -19.72% -0.67%
Net Operating Profit after Tax (NOPAT)
-2.19 49 77 -144 -25 98
NOPAT Margin
-7.18% 73.12% 36.40% -135.73% -21.24% 84.68%
Net Nonoperating Expense Percent (NNEP)
28.67% -53.41% 12.30% 603.06% 185.22% -860.43%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - 20.88%
Cost of Revenue to Revenue
74.05% 2.67% 22.37% 112.65% 0.00% 134.13%
SG&A Expenses to Revenue
15.54% 7.60% 8.38% 12.46% 11.20% 14.44%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
36.20% 23.75% 40.12% 181.26% 130.34% 11.44%
Earnings before Interest and Taxes (EBIT)
-0.41 26 93 -219 -39 4.21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
5.89 37 160 -137 27 69
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.05 0.00 2.32 1.83 1.17 0.41
Price to Tangible Book Value (P/TBV)
0.05 0.00 2.32 1.83 1.17 0.41
Price to Revenue (P/Rev)
0.29 0.00 4.28 2.56 2.57 1.61
Price to Earnings (P/E)
0.00 0.00 9.72 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 10.29% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.04 0.00 2.29 1.73 1.16 0.37
Enterprise Value to Revenue (EV/Rev)
0.26 0.00 4.33 2.75 2.64 1.36
Enterprise Value to EBITDA (EV/EBITDA)
1.33 0.00 5.71 0.00 11.70 2.28
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 9.81 0.00 0.00 37.13
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 11.89 0.00 0.00 1.60
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 9.40
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 3.39 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.02 0.17 0.08 0.18 0.10 0.04
Long-Term Debt to Equity
0.02 0.13 0.08 0.17 0.08 0.02
Financial Leverage
-0.01 -0.17 -0.09 0.06 0.07 -0.03
Leverage Ratio
0.15 0.64 1.22 1.21 1.23 1.18
Compound Leverage Factor
0.30 0.59 1.07 1.30 1.23 0.45
Debt to Total Capital
2.16% 14.39% 7.78% 15.49% 8.74% 3.94%
Short-Term Debt to Total Capital
0.00% 2.94% 0.00% 1.36% 1.57% 1.76%
Long-Term Debt to Total Capital
2.16% 11.45% 7.78% 14.13% 7.17% 2.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
97.84% 82.21% 92.22% 84.51% 91.26% 96.06%
Debt to EBITDA
0.73 0.58 0.21 -0.20 0.93 0.27
Net Debt to EBITDA
-0.18 -2.09 0.07 -0.15 0.31 -0.42
Long-Term Debt to EBITDA
0.73 0.46 0.21 -0.18 0.77 0.15
Debt to NOPAT
-1.96 0.44 0.43 -0.19 -0.99 0.19
Net Debt to NOPAT
0.49 -1.56 0.14 -0.14 -0.33 -0.30
Long-Term Debt to NOPAT
-1.96 0.35 0.43 -0.17 -0.82 0.10
Altman Z-Score
1.76 0.00 9.51 -1.85 2.14 1.28
Noncontrolling Interest Sharing Ratio
0.00% 1.58% 0.99% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
1.73 10.91 0.40 0.32 0.50 3.72
Quick Ratio
1.73 10.91 0.40 0.32 0.50 0.95
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 170 -250 86 -124 -57
Operating Cash Flow to CapEx
0.00% 110.98% 0.00% 0.00% 0.00% 16.38%
Free Cash Flow to Firm to Interest Expense
0.00 139.78 -64.53 21.81 0.00 -25.03
Operating Cash Flow to Interest Expense
-3.46 19.51 -26.20 -0.72 0.00 7.26
Operating Cash Flow Less CapEx to Interest Expense
-3.46 1.93 -26.20 -0.72 0.00 -37.08
Efficiency Ratios
- - - - - -
Asset Turnover
1.05 0.65 0.67 0.33 0.47 0.28
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 10.35
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.17 0.68 2.20 0.90 1.04 0.77
Accounts Payable Turnover
10.60 0.64 5.96 11.02 0.00 11.91
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 35.26
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
34.43 567.11 61.24 33.11 0.00 30.65
Cash Conversion Cycle (CCC)
-34.43 -567.11 -61.24 -33.11 0.00 4.60
Capital & Investment Metrics
- - - - - -
Invested Capital
193 73 400 169 268 420
Invested Capital Turnover
0.16 0.51 0.89 0.37 0.54 0.34
Increase / (Decrease) in Invested Capital
0.00 -120 327 -231 99 155
Enterprise Value (EV)
7.81 0.00 914 293 312 156
Market Capitalization
8.89 0.00 903 273 303 186
Book Value per Share
$0.59 $0.35 $5.01 $1.80 $2.89 $3.51
Tangible Book Value per Share
$0.59 $0.35 $5.00 $1.79 $2.89 $3.51
Total Capital
199 150 422 176 285 468
Total Debt
4.28 22 33 27 25 18
Total Long-Term Debt
4.28 17 33 25 20 10
Net Debt
-1.08 -77 11 20 8.22 -29
Capital Expenditures (CapEx)
0.00 21 0.00 0.00 0.00 102
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2.96 3.31 -13 -11 -15 140
Debt-free Net Working Capital (DFNWC)
2.17 102 -8.07 -6.83 -5.07 188
Net Working Capital (NWC)
2.17 98 -8.07 -9.23 -9.54 179
Net Nonoperating Expense (NNE)
-0.31 15 -2.75 92 26 101
Net Nonoperating Obligations (NNO)
-1.08 -55 11 20 8.22 -29
Total Depreciation and Amortization (D&A)
6.30 11 67 82 66 64
Debt-free, Cash-free Net Working Capital to Revenue
-9.71% 4.88% -6.34% -10.53% -12.51% 121.49%
Debt-free Net Working Capital to Revenue
7.11% 150.79% -3.82% -6.42% -4.30% 162.70%
Net Working Capital to Revenue
7.11% 144.30% -3.82% -8.68% -8.09% 155.57%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $3.00 $1.02 ($2.85) $0.00 ($0.02)
Adjusted Weighted Average Basic Shares Outstanding
0.00 13.88M 0.00 82.87M 90.01M 127.94M
Adjusted Diluted Earnings per Share
$0.00 $3.00 $0.94 ($2.85) $0.00 ($0.02)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 14.66M 0.00 82.87M 90.01M 127.94M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 180.01M 165.62M
Normalized Net Operating Profit after Tax (NOPAT)
-2.19 49 77 -76 -25 -42
Normalized NOPAT Margin
-7.18% 73.12% 36.40% -71.38% -21.24% -36.51%
Pre Tax Income Margin
-2.73% 35.89% 38.85% -222.10% -33.35% 1.40%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-0.99 21.71 24.06 -55.21 0.00 1.84
NOPAT to Interest Expense
-5.22 40.77 19.86 -36.42 0.00 42.63
EBIT Less CapEx to Interest Expense
-0.99 4.13 24.06 -55.21 0.00 -42.50
NOPAT Less CapEx to Interest Expense
-5.22 23.18 19.86 -36.42 0.00 -1.71
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for HIVE Blockchain Technologies

No quarterly metrics and ratios for HIVE Blockchain Technologies are available.



Financials Breakdown Chart

Frequently Asked Questions About HIVE Blockchain Technologies' Financials

When does HIVE Blockchain Technologies' fiscal year end?

According to the most recent income statement we have on file, HIVE Blockchain Technologies' financial year ends in March. Their financial year 2025 ended on March 31, 2025.

How has HIVE Blockchain Technologies' net income changed over the last 5 years?

HIVE Blockchain Technologies' net income appears to be on an upward trend, with a most recent value of -$3.00 million in 2025, rising from -$1.88 million in 2020. The previous period was $26.50 million in 2024.

What is HIVE Blockchain Technologies' operating income?
HIVE Blockchain Technologies' total operating income in 2025 was -$52.53 million, based on the following breakdown:
  • Total Gross Profit: -$39.34 million
  • Total Operating Expenses: $13.18 million
How has HIVE Blockchain Technologies' revenue changed over the last 5 years?

Over the last 5 years, HIVE Blockchain Technologies' total revenue changed from $30.49 million in 2020 to $115.28 million in 2025, a change of 278.0%.

How much debt does HIVE Blockchain Technologies have?

HIVE Blockchain Technologies' total liabilities were at $82.46 million at the end of 2025, a 74.4% increase from 2024, and a 928.5% increase since 2020.

How much cash does HIVE Blockchain Technologies have?

In the past 5 years, HIVE Blockchain Technologies' cash and equivalents has ranged from $4.37 million in 2023 to $40.29 million in 2021, and is currently $23.38 million as of their latest financial filing in 2025.

How has HIVE Blockchain Technologies' book value per share changed over the last 5 years?

Over the last 5 years, HIVE Blockchain Technologies' book value per share changed from 0.59 in 2020 to 3.51 in 2025, a change of 490.8%.



Financial statements for OTCMKTS:HVBTF last updated on 5/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners